These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 18190457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A, Stefanato CM, Ghosn S, Bhawan J.
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL, DiMaio DJ.
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
    Attis MG, Burchette JL, Selim MA, Pham T, Soler AP.
    Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S, Brousset P, Lamant L.
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A new piece in the melanoma mosaic--carcinosarcoma-like melanoma.
    Svec A, Wilkinson L, Bury Y, Martin VG.
    Histopathology; 2009 Sep; 55(3):366-8. PubMed ID: 19723157
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical aid at risk stratification of melanocytic neoplasms.
    Quatresooz P, Arrese JE, Pierard-Franchimont C, Pierard GE.
    Int J Oncol; 2004 Jan; 24(1):211-6. PubMed ID: 14654959
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB, Purohit C, Anglin TR.
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.